Compounds > spironolactone
Page last updated: 2024-08-17

spironolactone and marinobufagenin

spironolactone has been researched along with marinobufagenin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagrov, AY; Cooper, CJ; El-Okdi, N; Elkareh, J; Fedorova, OV; Gohara, S; Gupta, S; Haller, S; Malhotra, D; Periyasamy, SM; Shapiro, JI; Shidyak, A; Taleb, M; Tian, J; Xie, Z1
Bagrov, AY; Bagrov, KA; Emelianov, IV; Fedorova, OV; Frolova, EV; Grigorova, YN; Juhasz, O; Konradi, AO; Lakatta, EG; Marshall, CA; Wei, W1
Bagrov, AY; Egorov, AY; Kashkin, VA; Shekunova, EV1

Other Studies

3 other study(ies) available for spironolactone and marinobufagenin

ArticleYear
Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:6

    Topics: Animals; Bufanolides; Canrenone; Cardiomyopathies; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Drug Interactions; Endomyocardial Fibrosis; Fibroblasts; Mineralocorticoid Receptor Antagonists; Myocardium; Nephrectomy; Ouabain; Procollagen; Proline; Rats; Renal Insufficiency; Spironolactone; Tritium; Uremia

2009
Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
    Journal of hypertension, 2015, Volume: 33, Issue:8

    Topics: Animals; Aorta; Arterial Pressure; Bufanolides; Canrenone; Cells, Cultured; Collagen Type I; Endothelin-1; Erythrocytes; Female; Fibrosis; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitroprusside; Pulse Wave Analysis; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Spironolactone; Vasodilator Agents

2015
Marinobufagenin in Urine: A Potential Marker of Predisposition to Ethanol and a Target for Spironolactone.
    Current hypertension reviews, 2018, Volume: 14, Issue:1

    Topics: Alcohol Drinking; Animals; Behavior, Animal; Biomarkers; Blood Pressure; Bufanolides; Ethanol; Male; Mineralocorticoid Receptor Antagonists; Rats, Wistar; Spironolactone; Time Factors

2018